Protecting the nation from future
infectious diseases

Vision: Within 5 years, we will deliver an arsenal of tests, vaccines, and medicines to secure the nation’s health and economy.

Unleash Innovation

Celdara Medical was purpose-built to transform academic innovations into high-impact medicines. In concert with our affiliates Virtici (Seattle) and MBV (Indianapolis), we already work with hundreds of academic institutions representing over $10B/year in NIH research funding.

Celdara is the fastest-growing company in the state of New Hampshire (in all sectors, based on 3-year AAGR) for each of the last three years, and has been in the top 10 for each of the last six years, winning accolades from the NIH, SBA, and various Federal, state, and local agencies, as well as national and international publications. We have established academic innovation networks worldwide, and “boots on the ground” in Boston, New York, Indianapolis (MBV), and Seattle (Virtici).

Furthermore, we have – with the support of the NIH – established multi-state partnerships to improve medical entrepreneurship in Vermont, New Hampshire, Maine, Rhode Island and Delaware, as well as seven additional Western states (Alaska, Hawaii, Idaho, Montana, Nevada, New Mexico, and Wyoming, which Virtici leads). We work with the country’s major contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs), as well as most major biotech and pharma companies. Universities, pharmaceutical companies, CROs, and CDMOs to date have been unanimously supportive of the Pandemic Security Initiative.

 

A narrated introduction to the Pandemic Security Initiative

Finis Origine Pendet

View the Team

Pandemic Preparedness

The Pandemic Security Initiative is an integral part of the solution. Scientific funding, research, and innovation processes already work well. In parallel, we must continue the repurposing of drugs developed for other indications, as well as the development of rapid-response platforms. There is, however, a development gap between the invention of new tests, vaccines, and therapies, and our ability to stockpile them. The Pandemic Security Initiative proactively identifies the most promising medical countermeasures, and develops them to approved products to remove this development gap.
Download the Pandemic Security Initiative Info Sheet
Celdara Pandemic Security Initative Visual

Interested in learning more about the Pandemic Security Initiative?